The ODPRN Citizens’ Panel is a group of 20 volunteer citizens from across Ontario who have collectively come together to ensure that the ODPRN appropriately identifies issues of importance to the public, and incorporates these priorities into all aspects of our research.
Lorraine Bayliss | Elizabeth Bojarski | Priya Chendke | Hannah Dawson | Naana Dei | Terry Ebejer | Jennifer Jilks | Jerome Johnson | Matt Joosse | Kris Lee | Kristen Morin | Helen Patten | Zal Press | Suzanne Pierson | Josephine Quercia | Carlos Robayo | Debbie Rotenberg | Jane Sanders | Mike Stroh | Vincent Tourangeau
In addition to meeting bi-monthly by teleconference and annually in-person to provide their input on current research projects and deliverables, members also participated in a two-day workshop to define their role, structure and governance:
- Identifying priority research areas: Currently, members are collectively developing a research project of joint interest to policymakers, researchers and the general public based on aligned research priorities. The inaugural Panel-led project was our report on the Landscape of Prescription Stimulant Use.
- Integrating members with researchers & policymakers: This includes several leadership roles within the Citizens’ Panel, such as membership within our Stakeholder Advisory Panel and opportunities for engagement with drug policy makers.
- Participating on research teams: Currently, members are individually working on specific projects of interest to them throughout all stages of the research process, from developing the objectives to reviewing dissemination material, in order to ensure that our research is understandable to the general public.
- Enhancing patient engagement: Members are formally acknowledged on published material and have been instrumental in developing patient engagement tools including our online drug policy training modules.
The ODPRN is looking for a few more individuals to join our Citizens’ Panel. If you are interested in becoming a member, please email us at email@example.com for more information.